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ABSTRACT: Background: Perfluorinated chemicals (PFCs) have been used widely in consumer products since the 1950s and are
currently found at detectable levels in the blood of humans and animals across the globe. In stark contrast to this widespread
exposure to PFCs, there is relatively little research on potential adverse health effects of exposure to these chemicals. Objectives: We
performed this cross-sectional study to determine if specific blood PFC levels are associated with impaired response inhibition in
children. Methods: Blood levels of 11 PFCs were measured in children (N = 83) and 6 PFCs: perfluorooctane sulfonate (PFOS),
perfluorohexane sulfate (PFHxS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorooctanesulfonamide
(PFOSA), and perfluorodecanoic acid (PFDA) were found at detectable levels in most children (87.5% or greater had detectable
levels). These levels were analyzed in relation to the differential reinforcement of low rates of responding (DRL) task. This task
rewards delays between responses (i.e., longer inter-response times; IRTs) and therefore constitutes a measure of response
inhibition. Results: Higher levels of blood PFOS, PFNA, PFDA, PFHxS, and PFOSA were associated with significantly shorter IRTs
during the DRL task. The magnitude of these associations was such that IRTs during the task decreased by 2934% for every 1 SD
increase in the corresponding blood PFC. Conclusions: This study suggests an association between PFC exposure and children’s
impulsivity. Although intriguing, there is a need for further investigation and replication with a larger sample of children.
’ INTRODUCTION
Perfluoroalkyl acids constitute a general class of chemicals
that include a number of commonly used perfluorinated chemicals
(PFCs), including perfluorooctane sulfonate (PFOS), perfluorohex-
ane sulfate (PFHxS), and perfluorooctanoic acid (PFOA). These
chemicals have beenwidely used in consumer and industrial products.
With the widespread use of these chemicals and a marked resistance
tometabolic or environmental degradation, detectable levels of PFCs
have now been documented in wildlife around the world1,2 as well as
in humans with3 and without4,5 occupational exposure. Despite a
widespread exposure to this class of chemicals, relatively little is
known about potential effects to human health and behavior.
A number of studies have considered the potential effects of
prenatal exposure to PFOA and PFOS on birth outcomes in
humans. PFOA (but not PFOS) was associated with significantly
lower birth weight6 as well as smaller birth length and abdominal
circumference7 in the Danish National Birth Cohort. “Significance”
refers to statistical significance (not necessary clinical significance)
here and throughout this manuscript. In contrast to these significant
effects, another study found that PFOS (but not PFOA) were nega-
tively correlated with birth weight, and specifically in female infants.8
In addition, PFOA and PFOS were not significantly associated with
birth weight but both PFOA and PFOS were significantly associated
with lower ponderal index and head circumference.9 Finally, other
research has revealed no significant association between birth out-
comes and maternal PFC levels.10,11 Based on these inconsistencies,
additional research is necessary to determine if prenatal exposure to
certain PFCs are indeed related to birth outcomes12 and, if so, to
which outcomes.
In addition to the study of birth outcomes, a number of studies
have considered potential neurobehavioral effects of PFC ex-
posure in humans. For example, potential neurobehavioral conse-
quences of prenatal exposure toPFOAandPFOSwere considered in
the Danish National Birth Cohort.13,14 In this cohort, PFOS was
associated with delayed gross motor development in the first two
years of life14 but no other significant associations with develop-
mental milestones during the first two years of life or children’s
subsequent behavioral or coordination problems at age 7 were found
in this cohort.13 Two studies have considered children’s serum
PFOA, PFOS, PFNA, and PFHxS in relation to parental reports of
ADHD diagnosis (with and without medication). First, a cross-
sectional analysis of data from the National Health and Nutrition
Examination Survey (NHANES) 19992000 and 20032004 for
children 1215 years of age (N = 571) found significant adjusted
odds ratio (OR) for ADHD in association with a 1-μg/L increase in
serum PFOS (OR = 1.03; 95%CI: 1.011.05), PFOA (OR = 1.12;
95%CI: 1.011.23), and PFHxS (OR = 1.06; 95%CI: 1.021.11),
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but no significantly increased odds of ADHD for childrenwith higher
serum perfluorononanoic acid (PFNA15). Second, a cross-sectional
study was conducted with children 518 years of age (N = 10546)
in the C8 Health Project (a study of community residents in Ohio
and West Virginia who lived or worked in areas with PFOA-
contaminated water supplies16). In this study, the OR for ADD/
ADHD was significantly lower with increasing PFOA (OR = 0.80;
95% CI: 0.670.95) but significantly greater with increasing PFHxS
(OR= 1.33; 95%CI: 1.111.59), but no significant association with
PFOS or PFNA. The reason for the inconsistency across these
studies is not yet understood.
A number of studies have also considered the potential
reproductive and developmental effects of PFC exposure using
animal models. Initial studies were performed in the rat; however,
rats may not be the ideal species in which to study PFOA exposure
effects given rapid elimination of PFOA in female rats.17 Increasing
prenatal exposure to PFOA in rats was associated with diminished
postnatal weight gain and postweaning survival.18 Similarly, prenatal
exposure to PFOS was associated with greater postnatal mortality
and, for those that survived, developmental delays.19,20 Subsequent
studies with lower prenatal doses of PFOS in rats revealed greater
motor activity and diminished capacity to habituate to the testing
environment in offspring.21However, prenatal exposure toPFHxS in
rats produced no significant effects on mating, fertility, birth out-
comes, and development of offspring.22 In studies of prenatal ex-
posure to PFCs in mice, there was slightly diminished activity in
an open-field test with increasing PFOS.23 Similarly, neonatal ex-
posure to PFOS and PFOA was associated with diminished habitua-
tion to a novel environment and lack of activity (measured with
locomotion, rearing, and total activity;.24 Studies that have considered
combinedmaternal stress and prenatal exposure to PFOS have failed
to find any consistent interactions; however, increasing PFOS was
associated with fetal toxicity,25 decreased corticosterone levels in
females,26 and some evidence of delayed neuromotor maturation.27
The biological mechanism for potential PFC-induced neuro-
behavioral problems has yet to be determined. Perhaps prenatal PFC
exposure affects birth outcomes and, in turn, these birth outcomes
(e.g., birth weight) produce attentional problems.28 Alternatively,
PFCs might have direct effects on the central nervous system.
Although PFC exposure does not appear to produce differential
accumulation in the brain,29 it is detectable in brain tissue following
oral exposure.30 Furthermore, although PFC levels in brain tissue are
much lower than corresponding levels in serum, these levels might
still be sufficient to affect CNS functioning. For example, PFOS and
PFOAhave been shown to affect proteins in the brain thatmay affect
neuronal growth and synaptogenesis.31 Additional evidence suggests
that exposure to PFOS is associated with an increase in norepi-
nephrine concentrations in the paraventricular nucleus of the
hypothalamus,32 suggesting a possible pathway to nucleus accum-
bens activity33 and impulsivity.34 However, this particular neurobio-
logical pathway has yet to be established in humans.
In the present study, we conducted a cross-sectional investiga-
tion of potential emotional and behavioral associations with blood
PFC levels in children. Children are an important population given
the potential for a child’s environmental context to set a trajectory for
significant effects in adolescence and adulthood (e.g., ref 35).
Specifically, we considered potential PFC effects using a task shown
to be sensitive to environmental toxicant exposure, the differential
reinforcement of low rates of responding (DRL) task. TheDRL task
is a well-established behavioral measure of impulsivity36 affected by
exposure to a wide range of environmental toxicants.37 Therefore,
our study considers the hypothesis that increasing blood PFC levels
will be associated with increasing impulsivity in children asmeasured
using the DRL task.
’EXPERIMENTAL SECTION
Participants. Participants were recruited as part of an ongoing
study designed to address the effects of low level lead (Pb) exposure
on cardiovascular responses to acute stress.38 For that study (N =
100), we mailed invitations to homes in Oswego County, NY,
containing a child within our target age group (911) using a direct
mailing list. This recruitment method elicits participation from a
sample that closely resembles an eligible population and is cost-
effective.39 Further inclusion criteria included (1) reporting no use
on the day of testing of medication that might affect cardiovascular
functioning (e.g., Ritalin), and (2) having no significant develop-
mental disorders thatmight affect task performance (a component of
our broader study). After acquiring funding for the present study, we
began drawing an additional 2 mL of whole blood necessary for the
analysis of PFC levels after having already completed blood draws
and testing for 12 children. In addition, we were unable to obtain
sufficient blood for the additional analysis of PFC levels for five
children. For these five children (100% female), their initial veni-
puncture site closed during the draw and it was our policy to not
attempt a second venipuncture if we had sufficient blood for the
measurement of nonessential metals, the primary focus of our
project. It is unclear why this occurred exclusively with female
participants. With the exception of gender, this resulted in a final
sample of 83 children (30 females, 53 males) that did not differ
significantly from our full sample (N = 100) on any dimensions
measured with our covariates (e.g., BMI, race, and family income;
p values >0.10). In addition, gender was not significantly associated
with the PFCs we measured (p-values > 0.20).
Measurement of Blood PFC Levels. Participants arrived at
the blood draw center and signed an assent form while a parent
signed a separate consent form approved by the Institutional Review
Board of SUNY Oswego. As part of a more extensive blood draw
protocol, a whole blood specimen (2-mL) was collected into a
Vacutainer tube for the analysis of PFC blood levels. Blood speci-
mens were immediately placed on ice and within 2 h of the blood
draw the samples were transferred to 10 mL cryovials and frozen at
80 C pending shipment to Wadsworth Center, Albany, NY.
Chemical Analysis. PFOS, PFHxS, perfluorobutanesulfonate
(PFBS), perfluorodecanesulfonate (PFDS), perfluorooctanesul-
fonamide (PFOSA), perfluoroheptanoic acid (PFHpA), PFOA,
PFNA, perfluorodecanoic acid (PFDA), perfluoroundecanoic acid
(PFUnDA), and perfluorododecanoic acid (PFDoDA) were ana-
lyzed in whole blood samples using an ion-pairing extraction
procedure and were determined by use of high-performance liquid
chromatography-electrospray tandem mass spectrometry (HPLC-
ESI-MS/MS).40,41 Approximately 0.5 mL of blood sample, 5 ng of
internal standards (13C4PFOS, 13C4PFOA, 13C2PFNA, and
13C2PFDA), 2 mL of 0.25 M sodium carbonate/sodium bicarbo-
nate buffer and 1 mL of 0.8 M tetrabutyl ammonium hydrogen
sulfate solution (adjusted to pH 11), were added to a 15 mL
polypropylene tube for extraction. After thorough mixing, 5 mL of
methyl tert-butyl ether (MTBE) was added, and the mixture was
shaken for 40min. The organic and aqueous layerswere separated by
centrifugation at 3500 rpm for 3 min and an exact volume of MTBE
(4 mL) was removed from the solution. The aqueous mixture was
rinsed with 3 mL MTBE and separated twice; the rinses were
combined in a second polypropylene tube. The solvent was allowed
to evaporate gently under nitrogen streambefore being reconstituted
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in 0.5 mL of methanol. The sample was vortexed for 30 s and
transferred into an autosampler vial prior to instrumental analysis.
Analyte separation was performed using an Agilent1100 series
HPLC. Ten microliter of the extract was injected onto a 100 
2.1 mm (5 μm; Thermo Electron Corporation, Bellefonte, PA)
Betasil C18 columnwith 2mM ammonium acetate/methanol as the
mobile phase starting at 10%methanol. At aflow rate of 300μL/min,
the gradient increased to 100% methanol at 10 min before reverting
to original conditions at 12 min. For quantitative determination, the
HPLC system was interfaced to an API 2000 triple-quadruple
tandem mass spectrometer (Applied Biosystems, Foster City, CA)
operated in the electrospray negative ionization mode. Instrumental
parameters were optimized to transmit the [M-K] ion before
fragmentation to one or more product ions. Declustering potential
and collision energies were optimized for each analyte and ranged
from 35 to 90 V and 10 to 35 eV, respectively. Data were acquired by
tandem mass spectrometry using multiple reaction monitoring
(MRM) at transitions, 499 > 99 for PFOS, 503 > 99 for 13C4
PFOS, 497.7 > 77.7 for PFOSA, 398.7 > 79.7 for PFHxS, 298.7 >
79.7 for PFBS, 599 > 99 for PFDS, 363 > 319 for PFHpA, 413 > 369
for PFOA, 417 > 372 for 13C4PFOA, 463 > 419 for PFNA, 465 >
420 for 13C2PFNA, 513 > 469 for PFDA, 515 > 470 for
13C2PFDA, 563 > 519 for PFUnDA, and 613 > 169 for PFDoDA.
When possible, multiple daughter ions were monitored for con-
firmation, but quantitation was based on a single product ion. In all
cases, the capillary was held at4 kV and the desolvation tempera-
ture was kept at 400 C.
Quality Assurance and Quality Control. 13C4PFOS,
13C4PFOA (99% purity, Wellington Laboratories, Guelph,
ON, Canada), 13C2PFNA and 13C2PFDA (3 M Company,
St. Paul, MN) were spiked as internal standards into each blood
sample prior to the addition of reagents for extraction. PFC
concentrations were calculated by isotopic dilution method, and
further confirmed by matrix matched calibration standards. Recov-
eries of 13C4PFOS, 13C4PFOA, 13C2PFNA, and 13C2PFDA
were 98( 5%, 124( 7%, 109( 6%, and 141( 13%, respectively.
Matrix spike recoveries were tested by spikingnative standards of all
11 target compounds into 12 randomly selected samples, at levels of
10 ng and 20 ng for each of the target compounds. All the matrix
spike samples were analyzed in duplicate. Recoveries of native
standards spiked in blood matrix were 96 ( 6%, 101 ( 6%, 114
( 7%, and 105 ( 5%, for PFOS, PFHxS, PFOA, and PFNA,
respectively. The average recoveries for other perfluorochemicals
ranged from70% to 125%. The relative standard deviations (RSD)
of duplicate analyses were less than 5% for PFOS, PFHxS, PFBS,
PFDS, PFOA, PFNA, PFDA, PFHpA, and less than 10% for
PFOSA, PFUnDA, and PFDoDA. Milli-Q water (18 MΩ) was
analyzed through the entire procedure as a blank, for every batch of
20 samples. Procedure blanks were also spiked with native stan-
dards. The recoveries of native standards spiked in water blanks
were 96%, 85%, 108%, 109%, and 113% for PFOS, PFHxS, PFOA,
PFNA, and PFDA, respectively. Solvents and blood collection tubes
were checked for the presence of the perfluorochemicals analyzed in
this study. Concentrations in blanks are below limit of detection for
all eleven perfluorochemicals. The limit of quantitation (LOQ) was
determined based on the linear range of the calibration curve
prepared at a concentration range of 0.2100 ng/mL. Concentra-
tions in samples which were at least 3-fold greater than the lowest
acceptable standard concentration were considered to be valid. A
curve point was deemed acceptable if (1) it was back-calculated to
bewithin 30%of the theoretical valuewhen evaluated versus the 1/x
weighted curve, and (2) the peak area of the standard was at least 3
times greater than that in the blank. Concentration/dilution factors
were included in the calculation of the LOQ. The LOQ for PFOS
and PFOA was 0.2 and 1.0 ng/mL, and for other perfluorochem-
icals, it ranged from 0.2 to 1.0 ng/mL. Three of the perfluorochem-
icals (PFBS, PFDS, and PFUnDA) had levels below the LOQ for all
samples and are therefore not discussed further. Two of the
perfluorochemicals (PFHpA and PFDoDA) had more than 50%
of the samples below the LOQ and therefore results from the
analysis of these twoPFCs are not reported here (but are included in
our online Supporting Information (SI) Table S1). Total PFC
levels were computed by summing the remaining six PFCs, and
for those PFCs having some levels below the LOQ, 1/2 the value of
the LOQ for the particular PFC was used (cf., ref 42). For those 6
PFCs having levels above the LOQ in 50% of the children, separate
analyses were conducting for each PFC.
Procedure. All blood draws occurred on Friday and a labora-
tory session was scheduled for the following week. The laboratory
session commenced with the measurement of height and weight.
Unrelated to the present paper, all children underwent an initial
cardiovascular acute stress reactivity protocol for 1 h (see ref 38 for
details). These cardiovascular responses to acute stress were ana-
lyzed in relation to DRL performance (a 20 min task that followed
this cardiovascular stress testing) and PFC levels and are reported in
SI Table S2. The number of significant associations (5) was appro-
ximately what you would expect from chance and the analysis of 80
associations. In addition, the pattern of association (with early and
late DRL performance) does not coincide with PFC association
(with middle DRL performance).
Differential Reinforcement of Low Rates of Responding
(DRL) Task. As employed in a previous study that demonstrated
behavioral inhibition deficits as a function of toxicant exposure in
children,37 we adopted a relatively short (20 min) DRL task as an
assessment of learning rather than acquisition, which can take
hours37 or days.43 The present DRL task was presented using an
E-Prime (Psychology Software Tools, Inc.) program. Participants
were only told:
“You are now going to play a computer game in which you can
earn additional money. During this game, I will not be able to speak
to you. It is fine if you speak to me while you are playing, but I can’t
answer any questions. I will tell you when the game starts, and when
it’s over. I can’t tell you the rules to this game—you will need to
figure that out on your own. All I can tell you is that pressing the
button at the correct time is all that is involved in this game. If played
correctly, you could win as much as $15.00!”
The task was then begun and participants earned $.25 for the
first three responses and this was followed by a DRL20 schedule.
According to the DRL20 schedule, if the space bar was pressed
before the completion of 20 s, the time was reset to 20 s and no
money was earned. If a response (bar press) occurred 20 s or longer
following a prior response, $.25was earned and the computer screen
showed the following message: “CORRECT! You have earned
another $.25”. The program sequentially recorded the inter-re-
sponse time (IRT) of each bar press within a millisecond of
precision. IRTs represent the time between responses (i.e., bar
presses) and therefore rapid responding will be reflected by short
IRTs and delayed responding will be reflected by longer IRTs. The
IRTs were stored for subsequent analysis.
Potential Confounds. To strengthen our inferences regarding
the effects of children’s blood PFC levels, we considered a number
of potential confounds, including ages (child, mother, and father),
family income, parent’s education, parent’s occupational class, BMIs
(child,mother, and father), child’s gender, child’s race, family history
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of various chronic illnesses (e.g., diabetes), blood Pb levels, and
blood Hg levels (see Table 1 for a partial listing of these variables).
Details regarding the methods for measuring these variables are
included in the SI as well as in a prior publication.38
Emotional Response to the DRL. Participants were adminis-
tered the 16 itemBriefMood Introspection Scale (BMIS44). This
questionnaire includes a list of adjectives and requests partici-
pants to rate themselves on each item using a 4 point scale (1 =
definitely do not feel, 2 = do not feel, 3 = slightly feel, and 4 =
definitely feel). The BMIS was developed based on the assump-
tion of a pair of orthogonal mood dimensions (pleasant-unplea-
sant and arousal-calm) with a second set of dimensions (positive-
tired and negative-relaxed) at a 45 rotation from the first set.45
Items were appropriately reverse scored and averaged to create
scores on these four mood dimensions.
Data Analysis. DRL Performance Data. Median IRTs were
calculated from 5 min bins across the 20 min task. Median IRTs
were positively skewed and therefore a natural log transformation
was used to further normalize the data. In addition, the money a
child earned at this task was used as an index of overall performance.
Based on nonresponses during the task, four children were classified
as refusing. One child never pressed the bar/pad and three children
stopped pressing after the first 5 min.
Analytic Models.The distribution of blood PFC levels was not
normally distributed and was therefore log-transformed before
analysis. As an alternative approach to illustrate the data, the
online Supporting Information file contains the results of non-
parametric regressions on nontransformed data using the locally
weighted scatterplot smoothing method46 provided by SAS
PROC LOWESS. Furthermore, details regarding measurement
of all potential confound and results of bivariate analyses are
reported in the online SI. Using SAS PROC REG, DRL outcome
measures were regressed on PFC blood levels, controlling for all
potential confounds found to have a bivariate relationship to
outcome at p < 0.20. A similar approach to covariate selection has
been adopted in prior research37 and is considered a conservative
approach when controlling for potential confounds.47 As an
additional protection against results being a unique product of
our particular covariate selection method, the SI includes meth-
ods and results for a reanalysis of IRT data using a change-in-
estimate approach to covariate selection. As reported in the SI,
results were very similar using this alternative approach to
covariate selection. To avoid inflating our family wise error,
analyses of the four emotional dimensions assessed during the
DRL task were only conducted for total PFC concentrations.
’RESULTS AND DISCUSSION
Sample Characteristics. Table 1 shows characteristics of the
children and their mothers and fathers in this sample. By design,
children in our sample were 9, 10, or 11 years old (M = 10.13).
Associations between PFC levels and baseline characteristics are
reported in SI Table S4. Table 2 reports the PFC levels for the
children in the current sample. As shown in Table 3, levels of
different PFCs in the blood for this population were intercorre-
lated. Because PFC levels are not normally distributed, Spear-
man’s rank correlation coefficients are reported in Table 3. As
shown in Table 3, levels of total PFC primarily reflect levels of
PFOS, PFOA, and PFHxS. Although not the focus of the present
study, serum lipids were measured in this cohort. The partial
correlations between PFCs and these levels (controlling for
gender, a family history of high cholesterol, and family income)
are reported in SI Table S5. Although PFDA was significantly
correlated with total cholesterol and LDL, these significant
associations might be a result of a conducting numerous correla-
tions and a resulting Type I error.
Median IRTs.Themedian IRTs increased for each 5min “bin”
across the 20 min DRL task (2.95, 5.51, 8.90, and 13.40 s,
respectively), suggesting learning acquisition. After covariate control
for potential confounds, we considered the association of blood
PFC levels with median IRT. As shown in Table 4, increasing total
Table 1. Characteristics (Mean and SD or %) of Participants
(N = 83)
measure mean (SD)/%
child age (yrs) 10.13 (0.56)
mother’s age (yrs) 39.80 (5.85)
father’s age (yrs) 43.28 (9.34)
child’s BMI (kg/m2) 20.04 (3.92)
child’s Body Fat (%) 24.94 (5.63)
mother’s BMI (kg/m2) 27.50 (5.60)
father’s BMI (kg/m2) 29.49 (4.50)
child’s height (inches) 55.53 (2.81)
gender (0 = male; 1 = female) 36.14% female
race (0 = White; 1 = Other) 84.81%White
family History (0 = no; 1 = yes)
diabetes 37.35% yes
heart disease 43.37% yes
cholesterol 51.81% yes
high blood pressure 68.67% yes
stroke 19.28% yes
asthma 30.12% yes
blood Pb (mg/dL 1.01 (0.44)
blood Hg (mg/dL) 0.80 (1.39)
Table 2. PFC Content (ng/mL) in Blood Samples (Mean,
Standard Deviation, Median, Minimum, Maximum, % of
Samples with Levels Above LOQ) of Participants (N = 83)
mean SD median minimum maximum % above LOQ
total PFC 21.6 14.0 19.1 5.29 91.9 100.00
PFOS 9.90 6.09 8.79 1.13 32.6 100.00
PFOA 3.23 1.30 3.28 0.43 5.87 100.00
PFNA 0.82 0.55 0.72 0.10 (LOQ) 4.14 98.80
PFDA 0.26 0.13 0.26 0.10 (LOQ) 0.82 87.95
PFHxS 6.06 8.03 3.67 0.29 53.5 100.00
PFOSA 0.75 0.57 0.61 0.10 (LOQ) 4.03 98.80
Table 3. Spearman’s Rank Correlation Coefficients (rho)
among Different PFCs in Blood Samples (N = 83)
total PFC PFOS PFOA PFNA PFDA PFHxS PFOSA
PFOS 0.95d 1.00
PFOA 0.73d 0.71d 1.00
PFNA 0.16 0.14 0.31c 1.00
PFDA 0.38d 0.32c 0.48d 0.66d 1.00
PFHxS 0.77d 0.63d 0.37d 0.07 0.16 1.00
PFOSA 0.35c 0.33c 0.18 0.15 0.12 0.25b 1.00
a p < 0.10. b p < 0.05. c p < 0.01. d p < 0.001.
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PFCs were associated with significantly shorter IRTs at 510 min
and 1115 min (β s = 0.30, p-values < 0.01) as well as signifi-
cantly shorter IRTs at 1620 min (β =0.23, p < 0.05). Figure 1
shows the scatterplots for the association between total blood PFC
and IRTs. As can be seen in these figures, higher PFC blood levels
are associated with both shorter IRTs and smaller between-subject
variability. Associations with individual PFCs are also shown in
Table 4 and exhibit a similar pattern of associations; namely, the
weakest associations were found during the beginning of the task.
This pattern is not unusual for the DRL task (cf., ref 37) and reflects
the fact that differences in learning (and thereby performance) can
only emerge as exposure to the learning task progresses through time.
In order to illustrate the magnitude of significant effects using
the original units, Table 5 reports changes in median IRTs (in
seconds) and corresponding number of responses associated
with a 1 SD increase in the particular PFC. As shown in Table 5, a
1 SD increase in total PFC was associated with a decrease in
median IRT of 1.96, 3.65, and 8.27 s (for the 610, 1115, and
1620 min DRL periods, respectively) and a corresponding
increase in the number of responses to the task of 30.1, 23.4, and
50, during these same DRL periods. Expressed as a percent
change for those significant effects shown in Table 5, median IRT
decreased by 2934% for every 1 SD increase in the correspond-
ing blood PFC. The magnitude of effects for specific PFCs
(PFOS, PFNA, PFDA, PFHxS, and PFOSA) significantly asso-
ciated with reduced IRTs are also reported in Table 5.
Task Reward. As might be expected, poor performance (as
represented by short IRTs) resulted in significantly less money
being earned by those with increasing PFDA (β = 0.28, p <
0.05) and marginally less money for those with increasing blood
PFOS and PFOA (β = 0.19 and 0.21, respectively, p values
<0.10). In these analyses, covariates included father’s age, family
educational attainment, and a family history of diabetes.
Non-PFC Contaminants. Blood Pb and Hg were measured as
potential confounding contaminant exposures.37 Hg was not
associated with any outcome at p < 0.20 and therefore was not
included as a covariate in any model above. However, given the
significant positive association with blood PFCs and prior
findings of an association between prenatal MeHg and DRL
performance,37 we did repeat the analyses above with blood Hg
added as a covariate and, as expected, the results were unchanged.
Blood Pb was associated with IRTs during the 610 min period
and with the number of responses during the 1620 min time
period. However, when entered as covariates in the full model,
blood Pb was not significantly associated with these behavioral
outcomes (p values >0.10). This study did not have a sample
large enough to consider potential interactions between PFC and
either Pb or Hg exposure.
Task Emotion. Participants’ mood was assessed using the
BMIS following the DRL task. The analysis of the associations
between total PFC blood levels and the four mood dimensions
revealed no significant associations: pleasantunpleasant (β =
0.19,p=0.10), negativerelaxed (β=0.14,p>0.25), arousalcalm
(β = 0.01, p > 0.25), and positivetired (β =0.12, p > 0.25).
PFCs are ubiquitous environmental contaminants. In fact,
three PFCs that we measured (PFOS, PFOA, and PFHxS) were
found at detectable levels in all children in our sample. The present
study demonstrates that PFOS, PFNA, PFDA, PFHxS, PFOSA
levels in blood were all associated with significantly poorer perfor-
mance on a task requiring behavioral inhibition. The results demon-
strate significantly shorter IRTs and more frequent responses,
particularly in the middle of the task (between 5 and 15 min). In
addition, increasing blood PFDA was associated with children earn-
ing significantly lessmoneyduring this task. In short, increasing blood
levels for a number of different PFCs appear to be associated with
greater impulsivity in children and this translated into poor perfor-
mance on theDRL task. Although the pattern of associations did not
suggest an isolated effect of a particular PFC, this question is difficult
to address empirically in this sample because of the high intercorrela-
tions among the six individual PFCswemeasured at detectable levels.
In addition, although the concentration of some PFCs (PFOS and
PFOA) appear to have declined in the general U.S. population from
1999 to 2000 to 20032004,48 we still observed significant associa-
tions at levels apparent in 20082009. It remains to be determined
whether the apparent decline in PFOS and PFOA will continue or
plateau andwhether associationswith neurobehavioral outcomeswill
decline or continue. It is also unknown whether levels of PFCs other
than PFOS and PFOA are declining over time.
The association between PFCs and impulsivity (a defining
feature of ADHD) revealed in the present study might explain the
recently observed associations between PFC levels and ADHD.15
Two studies have now documented a significant increase in ADHD
risk associatedwith greater PFHxS 15,16 and our study demonstrated
a consistent association between PFHxS and impulsivity. However,
there remain a number of inconsistencies (e.g., a significant associa-
tion with ADHD/impulsivity was found for PFOS in our study and
Table 4. Relationship of PFC Blood Levels to Median IRTs within Each Time Period of the DRL Task (Standardized β and 95%
Confidence Intervals Are Shown; N = 79)a
DRL time period
PFC 05 minb 610 minc 1115 mind 1620 mine
total 0.11 [0.32, 0.10] 0.30** [0.50, 0.09] 0.30** [0.50, 0.09] 0.23* [0.45, 0.01]
PFOS 0.05 [0.26, 0.16] 0.18 [0.40, 0.04] 0.25* [0.46, 0.04] 0.20# [0.42, 0.02]
PFOA 0.03 [0.24, 0.18] 0.11 [0.34, 0.11] 0.20# [0.41, 0.01] 0.17 [0.39, 0.05]
PFNA 0.07 [0.29, 0.14] 0.24* [0.46, 0.02] 0.15 [0.38, 0.07] 0.05 [0.28, 0.18]
PFDA 0.09 [0.30, 0.13] 0.24* [0.45, 0.02] 0.23* [0.45, 0.02] 0.20# [0.43, 0.02]
PFHxS 0.13 [0.34, 0.09] 0.31** [0.53, 0.10] 0.20# [0.42, 0.02] 0.10 [0.32, 0.13]
PFOSA 0.13 [0.35, 0.08] 0.25* [0.46, 0.04] 0.17 [0.38, 0.05] 0.19# [0.42, 0.03]
a #, p < 0.10; *, p < 0.05; **, p < 0.01; ***, p < 0.001. bCovariates included a family history of diabetes, gender, race, father and child BMI, andmother’s age.
cCovariates included blood Pb, gender, body fat, parent’s education, family history of high blood pressure, and asthma. dCovariates included gender,
race, parent’s education, father’s age, family history of diabetes. eCovariates included race, father’s age, parent’s education, father’s BMI, and family
history of diabetes, heart disease, stroke, and high cholester.
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theNHANES sample, but not in theC8Health Project) that are not
readily explained. Finally, if exposure to particular PFCs represents
an increasing risk for impulsivity and a corresponding diagnosis of
ADHD, then do PFC levels in the environment “track” ADHD
prevalence rates? The increasing prevalence of ADHD49 coupled
with a decline in PFC levels48 appears inconsistent with the idea that
these two variables might be causally connected. However, not all
PFCs have been declining (e.g., PFNA48). Futhermore, it is not
known whether our cross-sectional measurement of blood PFC
levels in 911 year old children serves as an indirect measure of
prenatal or perinatal PFC exposure. Therefore, if neurotoxic effects
of PFCs occur specifically with prenatal or perinatal PFC exposure,
then a corresponding 911 year time-lag would be expected
between the environmental peak in PFC levels in the 1990s50 and
any corresponding peak in ADHD prevalence in children. Finally, a
potential link between temporal trends in environmental PFCs and
ADHDprevalencewould dependon an understanding of the nature
of the PFC-ADHD relationship (e.g., linear vs nonlinear). For
example, the results of smoothed nonparametric regression (see SI
Figure 1S) suggest a potential nonlinear association with no IRT-
PFC association (flat slope) at higher PFC levels. Therefore,
perhaps it is necessary for PFC levels to decline and reach an effect
threshold before ADHD prevalence rates are affected.
With respect to the generalizability of our findings, DRL tasks
vary in the particular response that is reinforced, the length of
the task, and the reinforcement schedule. For example, one DRL
task for children used points earned on a computer task and pro-
vided reinforcement of withholding responses for 6 s (a DRL-6
schedule51). In another study, the DRL apparatus included a
operant panel made to look like a clown’s face with marbles and
Figure 1. Relationship of total PFC concentrations in blood to IRTs during each DRL time period.
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money used to reward pushing the clown’s nose every 20 s.37 The
task used in the present study represents a relatively brief (20 min)
assessment of DRL-20 learning. Although most children did not
consistently respond every 20 s (i.e., learn the schedule), the
increase in IRTs over time demonstrates learning. More impor-
tantly, the significant associations emerged relatively quickly (after 5
min; cf., ref 37). Therefore, it is unlikely that the current associations
would differ as a function of the particular response, reward
employed, or task length. It is possible that different DRL schedules
are more (or less) sensitive to toxicant exposures however we have
no data with which to address this possibility.
There is a remarkable similarity between the PFC-DRL
associations in the present study and prior findings of associa-
tions between DRL performance and prenatal exposure to other
toxicants, namely polychlorinated biphenyls (PCBs) and Hg.37
There are two likely explanations for this similarity across studies.
Perhaps the current associations with PFCs emerged due to
underlying (and unmeasured) associations with prenatal expo-
sure to PCBs and Hg or, alternatively, those prior associations of
PCBs and Hg with DRL performance may have emerged due to
underlying (and unmeasured) associations with postnatal PFC
exposure (unfortunately, we were unable to measure PCBs due
to a lack of sufficient blood for this analysis). As partial support
for this idea, blood PFC and Hg levels were significantly
correlated in the present sample. PFC and Hg are likely
correlated due to a common food source for these toxicants,
namely fish.52 In contrast to prior findings for prenatal Hg
exposure,37 blood Hg for the present cohort was not found to
be significantly associated with DRL performance. Alternatively,
some environmental toxicants may exert effects on executive
control and response inhibition via multiple and separate path-
ways, all being sensitive to the final outcome as measured by the
DRL task. Additional study is clearly needed to gain an under-
standing of the mechanism by which blood PFC levels might
affect impulsivity, if such a causal pathway exists.
There are notable limitations with the present study. Fore-
most, we employed a cross-sectional study design making it
difficult to establish causality. For example, it is possible that
children’s impulsive behavior produced behaviors that increased
exposure to PFCs. Similarly, although we controlled for many
potential confounds, other variables (e.g., maternal and paternal
impulsivity) should be considered in future studies of PFC
exposure effects. The rationale would be that greater maternal
and paternal impulsivity might be associated with greater im-
pulsivity in their child as well as associated with greater PFC
exposure through consumer choices and differential exposure to
PFCs. In addition, other toxicants (e.g., PCBs) might be con-
founds however we did not have a sufficient volume of blood to
measure additional toxicant exposures. As a second limitation,
our sample was a subset drawn from a larger study of volunteers.
In addition, the sample used in the present analyses did not
include all children that volunteered, resulting in disproportio-
nately more males. However, gender was included as a covariate
when necessary and other potential covariates we measured were
not found to differ between our full sample and the subset drawn
for the present study. Finally, our DRL task was administered to
911 year old children during their second hour of testing. As
such, the 20 min we allowed for this task was not sufficiently long
to enable all children to achieve learning acquisition. Never-
theless, IRTs did increase during the task suggesting that, on
Table 5. Magnitude of Significant Associations Reported in Table 4, Expressed As the Change in Median IRTs (in Seconds) and
Number of Responses During DRL Period Associated with Each 1 Standard Deviation (SD) Increase in Blood PFC
1 SD increase in blood PFC
PFC DRL period
associated decrease from
median IRT (in sec) [95% confidence interval]
associated increase from median
number of responses [95% confidence interval]
total PFC (SD = 14.00 ng/mL)
610 min 5.51a1.96 [0.722.88] 54.4b þ 30.1 [8.259.7]
1115 min 8.90  3.65 [1.315.18] 33.7 þ 23.4 [5.846.9]
1620 min 13.40  8.27 [5.819.85] 22.4 þ 50 [17.162.1]
PFOS (SD = 6.09 ng/mL)
1115 min 8.90  2.73 [0.584.33] 33.7 þ 14.9 [2.431.9]
PFNA (SD = 0.56 ng/mL)
610 min 5.51  1.88 [0.142.45] 54.4 þ 28.2 [1.543.6]
PFDA (SD = 0.13 ng/mL)
610 min 5.511.62 [0.142.69] 54.4 þ 22.7 [1.552.0]
1115 min 8.903.01 [0.38  4.82] 33.7 þ 17.2 [1.539.8]
PFHxS (SD = 8.03 ng/mL)
610 min 5.511.79 [0.612.69] 54.4 þ 26.2 [6.852.0]
PFOSA (SD = 0.57 ng/mL)
610 min 5.511.71 [0.262.75] 54.4 þ 24.5 [2.754.3]
aThese represent the median IRT within the particular DRL period. bThese represent the median number of responses given the length of the DRL
period (5 min) and the median IRT.
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average, children were beginning to learn the reinforcement
schedule albeit at differing rates across differing blood PFC levels.
’CONCLUSIONS
The present study investigates blood levels of various PFCs in
children and associations with behavioral inhibition. The results
demonstrated significant associations between blood levels for
multiple PFCs and behavioral inhibition deficits in children as
measured using the DRL task. As a result, increasing blood PFC
levels were associated with earning significantly less money
during this task. These results are intriguing and suggest a need
for further investigation and replication with a larger sample of
children.
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